Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 2
2024 6
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 37639648

11 results

Results by year

Filters applied: . Clear all
Page 1
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU; Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Roy S, et al. J Clin Oncol. 2023 Nov 10;41(32):5005-5014. doi: 10.1200/JCO.23.00617. Epub 2023 Aug 28. J Clin Oncol. 2023. PMID: 37639648 Free PMC article.
Relationship between [18F]PSMA-1007 PET parameters and biochemical recurrence-free survival in high-risk prostate cancer patients receiving neoadjuvant hormonal treatment.
Ahmadi Bidakhvidi N, Giesen A, Devos G, Laenen A, Baldewijns M, Koole M, Deroose CM, Everaerts W, Joniau S, Goffin K. Ahmadi Bidakhvidi N, et al. Eur J Nucl Med Mol Imaging. 2026 Apr;53(5):2963-2973. doi: 10.1007/s00259-025-07631-2. Epub 2025 Nov 13. Eur J Nucl Med Mol Imaging. 2026. PMID: 41231407 Clinical Trial.
The contemporary management of prostate cancer.
Chakrabarti D, Albertsen P, Adkins A, Kishan A, Murthy V, Parker C, Pathmanathan A, Reid A, Sartor O, Van As N, Walz J, Tree A. Chakrabarti D, et al. CA Cancer J Clin. 2025 Nov-Dec;75(6):552-586. doi: 10.3322/caac.70020. Epub 2025 Jun 26. CA Cancer J Clin. 2025. PMID: 40572035 Free PMC article. Review.
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
Ravi P, Xie W, Buyse M, Halabi S, Kantoff PW, Sartor O, Attard G, Clarke N, D'Amico A, Dignam J, James N, Fizazi K, Gillessen S, Parulekar W, Sandler H, Spratt DE, Sydes MR, Tombal B, Williams S, Sweeney CJ. Ravi P, et al. Eur Urol. 2025 Feb;87(2):217-224. doi: 10.1016/j.eururo.2024.04.038. Epub 2024 May 22. Eur Urol. 2025. PMID: 38777647 Free PMC article.
11 results